Silicon Valley Capital Partners »

AstraZeneca shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $37k 549 67.69
2023-12-31 $36k 541 67.30
2023-09-30 $41k 601 67.67
2023-06-30 $43k 597 71.52
2023-03-31 $4.1k 60 68.90
2022-12-31 $4.0k 59 67.49

More positions owned by Silicon Valley Capital Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Invesco S&p 500 Garp Etf Etf (SPGP)
Invesco Qqq Trust Series I Etf (QQQ)
Apple Stock (AAPL)
Vanguard Information Technology Etf Etf (VGT)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Nvidia Corporation Stock (NVDA)
Ishares S&p 500 Growth Etf Etf (IVW)
Amazon Stock (AMZN)
Vanguard Growth Etf Etf (VUG)
Vanguard Mega Cap Value Etf Etf (MGV)
Goldman Sachs Activebeta U.s. Large Cap Equity Etf Etf (GSLC)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Starbucks Corp Stock (SBUX)

View all positions for Silicon Valley Capital Partners

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
Jennison Associates
Sanders Capital
Goldman Sachs Group
Bank of America Corporation
Franklin Resources
Fisher Investments
Holocene Advisors
Dimensional Fund Advisors
ClearBridge Advisors
Jpmorgan Chase & Co
WCM Investment Management
Wells Fargo & Company

View all funds holding AstraZeneca